NO944287L - Anvendelse av terfenadinderivater som antihistaminmidler i en hepatisk svekket pasient - Google Patents

Anvendelse av terfenadinderivater som antihistaminmidler i en hepatisk svekket pasient

Info

Publication number
NO944287L
NO944287L NO944287A NO944287A NO944287L NO 944287 L NO944287 L NO 944287L NO 944287 A NO944287 A NO 944287A NO 944287 A NO944287 A NO 944287A NO 944287 L NO944287 L NO 944287L
Authority
NO
Norway
Prior art keywords
hydrogen
impaired patient
hepatically impaired
patient
antihistamine agents
Prior art date
Application number
NO944287A
Other languages
English (en)
Other versions
NO307688B1 (no
NO944287D0 (no
Inventor
James Kenneth Woodward
Richard Arthur Okerholm
Mark Gordon Eller
Bruce Edward Mcnutt
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27128589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO944287(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO944287L publication Critical patent/NO944287L/no
Publication of NO944287D0 publication Critical patent/NO944287D0/no
Publication of NO307688B1 publication Critical patent/NO307688B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO944287A 1992-05-11 1994-11-10 Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat NO307688B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88080192A 1992-05-11 1992-05-11
US92289092A 1992-07-31 1992-07-31
PCT/US1993/003151 WO1993023047A1 (en) 1992-05-11 1993-04-06 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient

Publications (3)

Publication Number Publication Date
NO944287L true NO944287L (no) 1994-11-10
NO944287D0 NO944287D0 (no) 1994-11-10
NO307688B1 NO307688B1 (no) 2000-05-15

Family

ID=27128589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944287A NO307688B1 (no) 1992-05-11 1994-11-10 Anvendelse av terfenadinderivater som antihistaminmidler i et farmasøytisk preparat

Country Status (16)

Country Link
US (7) US6037353A (no)
EP (1) EP0639976B1 (no)
JP (1) JPH07506828A (no)
KR (1) KR950701525A (no)
AT (1) ATE194913T1 (no)
AU (1) AU679910B2 (no)
CA (1) CA2134211C (no)
CL (1) CL2004000304A1 (no)
DE (1) DE69320952T2 (no)
DK (1) DK0639976T3 (no)
ES (1) ES2121084T3 (no)
HU (1) HU223774B1 (no)
MX (1) MX9302704A (no)
NO (1) NO307688B1 (no)
NZ (1) NZ251834A (no)
WO (1) WO1993023047A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ251834A (en) * 1992-05-11 1997-07-27 Merrell Dow Pharma Use of acid derivatives of terfenadine as antihistamines
RU2167657C2 (ru) * 1992-08-03 2001-05-27 Сепракор, Инк. Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
WO1995010278A1 (en) * 1993-10-15 1995-04-20 Hoechst Marion Roussel, Inc. Treatment of allergic disorders with terfenadine carboxylate
IT1271417B (it) * 1993-10-15 1997-05-28 Erregierre Ind Chim Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CN1623985A (zh) * 1994-05-18 2005-06-08 阿温蒂斯药物公司 抗组胺哌啶衍生物，其多晶形物和假同晶物的无水和水合物形式的制备方法
DE69624559T2 (de) 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
EP0998272B1 (en) * 1997-08-26 2003-05-02 Aventis Pharmaceuticals Inc. Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
MXPA03009259A (es) * 2001-04-09 2004-06-03 Teva Pharma Polimorfos de clorhidrato de fexofenadina.
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
WO2003104197A1 (en) * 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
EP1393728A1 (en) * 2002-08-30 2004-03-03 Vrije Universiteit Inverse agonists acting at virus-encoded G protein-coupled receptors
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
WO2005102999A2 (en) * 2004-04-26 2005-11-03 Teva Pharmaceutical Industries Ltd. Crystalline forms of fexofenadine hydrochloride and processes for their preparation
EP1685106A2 (en) * 2004-09-28 2006-08-02 Teva Pharmaceutical Industries, Inc. Fexofendadine crystal form and processes for its preparation thereof
US20090076080A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched fexofenadine
KR20110017365A (ko) * 2008-05-30 2011-02-21 페어필드 클리니컬 트라이얼즈 엘엘씨 피부 염증 및 변색을 위한 방법 및 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
NZ251834A (en) * 1992-05-11 1997-07-27 Merrell Dow Pharma Use of acid derivatives of terfenadine as antihistamines
RU2167657C2 (ru) * 1992-08-03 2001-05-27 Сепракор, Инк. Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата

Also Published As

Publication number Publication date
US20100168166A1 (en) 2010-07-01
HU223774B1 (hu) 2005-01-28
DK0639976T3 (da) 1999-02-15
DE69320952D1 (de) 1998-10-15
DE69320952T2 (de) 1999-05-27
HUT71402A (en) 1995-11-28
CL2004000304A1 (es) 2005-05-27
NO307688B1 (no) 2000-05-15
ES2121084T3 (es) 2002-02-16
ATE194913T1 (de) 2000-08-15
US20060205782A1 (en) 2006-09-14
MX9302704A (es) 1994-06-30
US6187791B1 (en) 2001-02-13
AU3973493A (en) 1993-12-13
NO944287D0 (no) 1994-11-10
KR950701525A (ko) 1995-04-28
WO1993023047A1 (en) 1993-11-25
US20030055083A1 (en) 2003-03-20
AU679910B2 (en) 1997-07-17
NZ251834A (en) 1997-07-27
JPH07506828A (ja) 1995-07-27
CA2134211C (en) 1999-06-29
EP0639976B1 (en) 2000-07-26
US20030130315A1 (en) 2003-07-10
US6037353A (en) 2000-03-14
EP0639976A1 (en) 1995-03-01
CA2134211A1 (en) 1993-11-25
US6399632B1 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
NO944287D0 (no) Anvendelse av terfenadinderivater som antihistaminmidler i en hepatisk svekket pasient
FI956248A0 (fi) Uusia välituotteita antihistamiinisten 4-difenyylimetyyli/difenyylimetoksipiperidiinijohdannaisten valmistusta varten
ES2148305T3 (es) Derivados de aminoacidos ciclicos que tienen actividad inhibidora de ace y nep.
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
DE69122812D1 (de) Glutathionderivat
ATE172959T1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
ATE255121T1 (de) Antitumor-indolopyrolocarbazolderivat

Legal Events

Date Code Title Description
MK1K Patent expired